Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal Bevacizumab | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal Bevacizumab	Diabetes Complications, Embolism and Thrombosis, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Venous Thrombosis, butyrylcholinesterase deficiency, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, glucose metabolism disease, macular degeneration, metabolic disease, retinal degeneration, retinal disorder, retinal vein occlusion, thrombotic disease, vascular disorder	Recruiting	Not stated	2026-04-24		NCT07550777

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Ataturk University	120

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ataturk University Research Hospital, Department of Ophthalmology	Erzurum	Turkey (Türkiye)	1